Stocksigma LogoStocksigma Logo

Alkem Laboratories Concludes US FDA Inspection at Mandva API Facility with Zero Form 483 Observations

Alkem Laboratories announced that the US FDA successfully concluded an inspection at its API manufacturing facility located in Mandva

Alkem Laboratories Concludes US FDA Inspection at Mandva API Facility with Zero Form 483 Observations

Alkem Laboratories Ltd 路 Press Release 路 30 Oct 2026, 8:52 pm

Alkem Laboratories Concludes US FDA Inspection at Mandva API Facility with Zero Form 483 Observations Alkem Laboratories announced that the US FDA successfully concluded an inspection at its API manufacturing facility located in Mandva. The regulatory audit was conducted from 26th Oct'26 to 30th Oct'26 and concluded with zero Form 483 observations, confirming strong compliance standards and mitigating regulatory overhang for the site.

Original exchange filing (PDF)

More announcements from Alkem Laboratories Ltd

All Alkem Laboratories Ltd announcements